Business Description
CapsoVision Inc
NAICS : 339112
SIC : 3845
ISIN : US1409351079
Total Employee Number:
99Description
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.21 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 18.81 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 46.36 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 43.45 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.57 | |||||
9-Day RSI | 66.58 | |||||
14-Day RSI | 57.19 | |||||
3-1 Month Momentum % | -7.73 | |||||
6-1 Month Momentum % | 28.71 | |||||
12-1 Month Momentum % | 84.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.35 | |||||
Quick Ratio | 2.44 | |||||
Cash Ratio | 1.76 | |||||
Days Inventory | 186.28 | |||||
Days Sales Outstanding | 54.72 | |||||
Days Payable | 58.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50.88 | |||||
Operating Margin % | -217.09 | |||||
Net Margin % | -214.74 | |||||
EBITDA Margin % | -212.81 | |||||
FCF Margin % | -200.77 | |||||
OCF Margin % | -200.28 | |||||
ROA % | -152.37 | |||||
ROIC % | -563.5 | |||||
ROC (Joel Greenblatt) % | -722.02 | |||||
ROCE % | -203.53 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 22.26 | |||||
PB Ratio | 25.08 | |||||
Price-to-Tangible-Book | 25.04 | |||||
EV-to-EBIT | -10.54 | |||||
EV-to-EBITDA | -10.75 | |||||
EV-to-Revenue | 22.89 | |||||
EV-to-Forward-Revenue | 15.6 | |||||
EV-to-FCF | -11.4 | |||||
| Price-to-Net-Current-Asset-Value | 27.13 | |||||
| Price-to-Net-Cash | 93 | |||||
Earnings Yield (Greenblatt) % | -9.49 | |||||
FCF Yield % | -8.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CapsoVision Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13.891 | ||
| EPS (TTM) ($) | -0.628 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 118.65 | ||
| 14-Day RSI | 57.19 | ||
| 14-Day ATR ($) | 0.372931 | ||
| 20-Day SMA ($) | 6.11125 | ||
| 12-1 Month Momentum % | 84.02 | ||
| 52-Week Range ($) | 3.6001 - 15.37 | ||
| Shares Outstanding (Mil) | 50.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CapsoVision Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CapsoVision Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 64 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 63 days | ||
| H.C. Wainwright 28th Annual Global Investment Conference | 2026-09-11 07:00 | In 1 day | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 16:30 | 6.86 (+3.78%) | ||
| Second quarter earnings results for 2026 | 2026-08-13 | 6.86 (+3.78%) | ||
| General meeting for 2025 | 2026-06-11 09:00 | 7.24 (-1.03%) | ||
| First quarter earnings conference call for 2026 | 2026-05-14 13:30 | 7.00 (-1.55%) | ||
| First quarter earnings results for 2026 | 2026-05-14 | 7.00 (-1.55%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-26 16:30 | 8.27 (-4.17%) | ||
| Annual report for 2025 | 2026-03-26 | 8.27 (-4.17%) |
Show
Entries
CapsoVision Inc Frequently Asked Questions
What is CapsoVision Inc(CV)'s stock price today?
The current price of CV is $6.51. The 52 week high of CV is $15.37 and 52 week low is $3.60.
When is next earnings date of CapsoVision Inc(CV)?
The next earnings date of CapsoVision Inc(CV) is 2026-11-13 Est..
Does CapsoVision Inc(CV) pay dividends? If so, how much?
CapsoVision Inc(CV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers